Phase II Randomized Trial of Pazopanib Vs. Local Therapy for Renal Cell Carcinoma Patients With Limited Metastases

Trial Profile

Phase II Randomized Trial of Pazopanib Vs. Local Therapy for Renal Cell Carcinoma Patients With Limited Metastases

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs Pazopanib (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2017 Planned primary completion date changed from 1 Dec 2019 to 31 Dec 2020.
    • 21 Jun 2017 Planned initiation date changed from 1 Nov 2016 to 15 Jul 2017.
    • 09 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top